Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycine Receptor Subunit Alpha-3 (GLRA3)
- Target
- GLRA3
- Molecular classification
- Ligand-gated ion channel, Ionotropic receptor
01
Overview
The glycine receptor subunit alpha-3 (GLRA3) is a subunit of the glycine receptor, a pentameric ligand-gated chloride channel that mediates inhibitory neurotransmission in the central nervous system. GLRA3 plays a critical role in down-regulating neuronal excitability, particularly in the spinal cord dorsal horn, influencing pain perception and other sensory processing. Modulation of GLRA3 activity is a potential therapeutic target for analgesia and other neurological conditions.
- Other names
- Glycine receptor alpha 3 subunitGLRα3
02
Mechanism of action
Channel opening (agonists); competitive block (antagonists); potentiation (modulators)
03
Biological functions
Inhibitory neurotransmissionDown-regulation of neuronal excitabilityModulation of postsynaptic currentsSensory processingPain perception
04
Disease associations
Chronic pain syndromesInflammationSensory processing disorders
05
Safety considerations
Potential for off-target effects due to sequence similarity with other glycine receptor subunits.Development of tolerance or dependence with chronic agonist use.
06
Interacting drugs
Glycine
5 more in the full profile.
Beyond the preview
Go deeper on Glycine Receptor Subunit Alpha-3 (GLRA3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glycine Receptor Subunit Alpha-3 (GLRA3).